Scientists hunt Cancer's genetic blueprint to match patients with best drugs
NCT ID NCT02735252
Summary
This study aims to understand why some cancer treatments work for certain patients but not others. Researchers will collect tumor tissue and blood samples from 156 people with advanced prostate, kidney, or bladder cancer who are about to start a new treatment. By analyzing the genetic makeup of the tumors, they hope to find patterns that can predict which patients will benefit most from specific therapies like immunotherapy or targeted drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.